BRIAN G ATWOOD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRIAN G ATWOOD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN G ATWOOD. BRIAN G ATWOOD is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in PHARMION CORP ($PHRM) and Director in OPGEN INC ($OPGN) and Director in VERACYTE, INC. ($VCYT) and Director in PHASERX, INC. ($PZRX) and Director in Immune Design Corp. ($IMDZ) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Atreca, Inc. ($BCEL) and Director in Locust Walk Acquisition Corp. ($LWAC).
Latest Insider Trading Transactions of BRIAN G ATWOOD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCEL, CLVS, FPRX, IMDZ, LWAC, OPGN, PHRM, PZRX, VCYT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | A | 10.27 | 12,000 | 123,240 | 12,000 | |
Jan 14 2021 | LWAC | Locust Walk Acquis ... | ATWOOD BRIAN G | Director | Option Exercise | J | 0.00 | 25,000 | 0 | 25,000 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 12.66 | 34,166 | 432,542 | 34,166 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 12.66 | 34,166 | 432,542 | 0 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 4.56 | 12,500 | 57,000 | 12,500 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 4.56 | 12,500 | 57,000 | 0 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 17.87 | 12,000 | 214,440 | 12,000 | |
Dec 10 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | G | 17.87 | 12,000 | 214,440 | 0 | |
Jun 15 2020 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | A | 17.87 | 12,000 | 214,440 | 12,000 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Aug 22 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | M | 0.29 | 25,862 | 7,500 | 0 | |
Aug 22 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | M | 0.29 | 25,862 | 7,500 | 25,862 | 0 to 25.9 K |
Jun 24 2019 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 4,287 | 0 | 0 | |
Jun 24 2019 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 4,504 | 0 | 0 | |
Jun 24 2019 | BCEL | Atreca, Inc. | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 8,791 | 0 | 49,654 | 40.9 K to 49.7 K (+21.51 %) |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 2,882 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 2,882 | |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
Jun 28 2017 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 4,998 | 0 | 25,577 | 20.6 K to 25.6 K (+24.29 %) |
Jun 28 2017 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 212 | 0 | 20,579 | 20.4 K to 20.6 K (+1.04 %) |
Jun 08 2017 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 59.56 | 10,000 | 595,600 | 10,000 | |
May 30 2017 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
Jun 24 2016 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Option Exercise | A | 1.35 | 12,500 | 16,875 | 12,500 | |
Jun 20 2016 | VCYT | VERACYTE, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 5.28 | 10,000 | 52,800 | 10,000 | |
Jun 10 2016 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 15.23 | 10,000 | 152,300 | 10,000 | |
Jun 03 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 5.08 | 28,203 | 143,271 | 28,203 | |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 596,477 | 2,982,385 | 1,931,094 | 1.3 M to 1.9 M (+44.69 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 182,914 | 1,829 | 1,334,617 | 1.5 M to 1.3 M (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 73,615 | 736 | 1,517,531 | 1.6 M to 1.5 M (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 3,523 | 17,615 | 11,408 | 7.9 K to 11.4 K (+44.68 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 1,080 | 11 | 7,885 | 9 K to 7.9 K (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 435 | 4 | 8,965 | 9.4 K to 9 K (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 596,477 | 2,982,385 | 1,931,094 | 1.3 M to 1.9 M (+44.69 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 182,914 | 1,829 | 1,334,617 | 1.5 M to 1.3 M (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 73,615 | 736 | 1,517,531 | 1.6 M to 1.5 M (-4.63 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Buy | P | 5.00 | 3,523 | 17,615 | 11,408 | 7.9 K to 11.4 K (+44.68 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 1,080 | 11 | 7,885 | 9 K to 7.9 K (-12.05 %) |
May 24 2016 | PZRX | PHASERX, INC. | ATWOOD BRIAN G | Director | Sell | S | 0.01 | 435 | 4 | 8,965 | 9.4 K to 9 K (-4.63 %) |
Jan 06 2016 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jun 16 2015 | FPRX | FIVE PRIME THERAPE ... | ATWOOD BRIAN G | Director | Option Exercise | A | 22.15 | 12,500 | 276,875 | 12,500 | |
Jun 15 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 87.15 | 10,000 | 871,500 | 10,000 | |
May 21 2015 | VCYT | VERACYTE, INC. | ATWOOD BRIAN G | Director | Option Exercise | A | 10.41 | 10,000 | 104,100 | 10,000 | |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 6,729 | 0 | 20,367 | 13.6 K to 20.4 K (+49.34 %) |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 283 | 0 | 13,638 | 13.4 K to 13.6 K (+2.12 %) |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Sell | J | 0.00 | 2,550 | 0 | 2,550 | 5.1 K to 2.6 K (-50.00 %) |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Sell | J | 0.00 | 91,279 | 0 | 0 | 91.3 K to 0 (-100.00 %) |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 91,279 | 0 | 91,279 | 0 to 91.3 K |
May 18 2015 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Sell | J | 0.00 | 404,867 | 0 | 404,866 | 809.7 K to 404.9 K (-50.00 %) |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Option Exercise | P | 6.60 | 413,332 | 2,727,991 | 413,332 | |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 503,522 | 0 | 0 | |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 404,725 | 0 | 0 | |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 1,160,039 | 0 | 0 | |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 503,522 | 0 | 2,554,211 | 2.1 M to 2.6 M (+24.55 %) |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 404,725 | 0 | 2,050,689 | 1.6 M to 2.1 M (+24.59 %) |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 1,160,039 | 0 | 1,645,964 | 485.9 K to 1.6 M (+238.73 %) |
May 12 2015 | OPGN | OPGEN INC | ATWOOD BRIAN G | Director | Buy | P | 6.00 | 413,332 | 2,479,992 | 485,925 | 72.6 K to 485.9 K (+569.38 %) |
Feb 24 2005 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 6,622 | 0 | 15,201 | 8.6 K to 15.2 K (+77.19 %) |
Feb 24 2005 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | J | 0.00 | 469,097 | 0 | 0 | 469.1 K to 0 (-100.00 %) |
Oct 28 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 7,192 | 0 | 8,399 | 1.2 K to 8.4 K (+595.86 %) |
Oct 28 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | J | 0.00 | 469,099 | 0 | 469,097 | 938.2 K to 469.1 K (-50.00 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.45 | 1,000 | 37,450 | 938,194 | 939.2 K to 938.2 K (-0.11 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.40 | 300 | 11,220 | 939,194 | 939.5 K to 939.2 K (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.34 | 100 | 3,734 | 939,494 | 939.6 K to 939.5 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.32 | 100 | 3,732 | 939,594 | 939.7 K to 939.6 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.30 | 100 | 3,730 | 939,694 | 939.8 K to 939.7 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.25 | 400 | 14,900 | 939,794 | 940.2 K to 939.8 K (-0.04 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.23 | 200 | 7,446 | 940,194 | 940.4 K to 940.2 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.22 | 600 | 22,332 | 940,394 | 941 K to 940.4 K (-0.06 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.50 | 3,400 | 124,100 | 975,094 | 978.5 K to 975.1 K (-0.35 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.45 | 200 | 7,290 | 978,494 | 978.7 K to 978.5 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.43 | 100 | 3,643 | 978,694 | 978.8 K to 978.7 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.42 | 300 | 10,926 | 978,794 | 979.1 K to 978.8 K (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.40 | 4,400 | 160,160 | 979,094 | 983.5 K to 979.1 K (-0.45 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.27 | 400 | 14,508 | 983,494 | 983.9 K to 983.5 K (-0.04 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.25 | 3,500 | 126,875 | 983,894 | 987.4 K to 983.9 K (-0.35 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.24 | 500 | 18,120 | 987,394 | 987.9 K to 987.4 K (-0.05 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.22 | 300 | 10,866 | 987,894 | 988.2 K to 987.9 K (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.21 | 100 | 3,621 | 988,194 | 988.3 K to 988.2 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.20 | 1,700 | 61,540 | 988,294 | 990 K to 988.3 K (-0.17 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.19 | 100 | 3,619 | 989,994 | 990.1 K to 990 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.18 | 900 | 32,562 | 990,094 | 991 K to 990.1 K (-0.09 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.16 | 1,900 | 68,704 | 990,994 | 992.9 K to 991 K (-0.19 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.15 | 2,500 | 90,375 | 992,894 | 995.4 K to 992.9 K (-0.25 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.13 | 100 | 3,613 | 995,394 | 995.5 K to 995.4 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.10 | 1,900 | 68,590 | 995,494 | 997.4 K to 995.5 K (-0.19 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.08 | 800 | 28,864 | 997,394 | 998.2 K to 997.4 K (-0.08 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.02 | 2,300 | 82,846 | 998,194 | 1 M to 998.2 K (-0.23 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.00 | 6,500 | 234,000 | 1,000,494 | 1 M to 1 M (-0.65 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.93 | 5,400 | 194,022 | 1,006,994 | 1 M to 1 M (-0.53 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.92 | 100 | 3,592 | 1,012,394 | 1 M to 1 M (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.91 | 400 | 14,364 | 1,012,494 | 1 M to 1 M (-0.04 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.90 | 20,000 | 718,000 | 1,012,894 | 1 M to 1 M (-1.94 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.89 | 1,700 | 61,013 | 1,032,894 | 1 M to 1 M (-0.16 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.88 | 400 | 14,352 | 1,034,594 | 1 M to 1 M (-0.04 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.87 | 200 | 7,174 | 1,034,994 | 1 M to 1 M (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.86 | 800 | 28,688 | 1,035,194 | 1 M to 1 M (-0.08 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.85 | 200 | 7,170 | 1,035,994 | 1 M to 1 M (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 35.76 | 2,000 | 71,520 | 1,036,194 | 1 M to 1 M (-0.19 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.20 | 8,900 | 331,080 | 940,994 | 949.9 K to 941 K (-0.94 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.17 | 100 | 3,717 | 949,894 | 950 K to 949.9 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.15 | 6,300 | 234,045 | 949,994 | 956.3 K to 950 K (-0.66 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 37.00 | 5,000 | 185,000 | 956,294 | 961.3 K to 956.3 K (-0.52 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.98 | 600 | 22,188 | 961,294 | 961.9 K to 961.3 K (-0.06 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.96 | 100 | 3,696 | 961,894 | 962 K to 961.9 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.86 | 300 | 11,058 | 961,994 | 962.3 K to 962 K (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.85 | 100 | 3,685 | 962,294 | 962.4 K to 962.3 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.81 | 100 | 3,681 | 962,394 | 962.5 K to 962.4 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.80 | 500 | 18,400 | 962,494 | 963 K to 962.5 K (-0.05 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.76 | 500 | 18,380 | 962,994 | 963.5 K to 963 K (-0.05 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.75 | 100 | 3,675 | 963,494 | 963.6 K to 963.5 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.74 | 500 | 18,370 | 963,594 | 964.1 K to 963.6 K (-0.05 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.73 | 200 | 7,346 | 964,094 | 964.3 K to 964.1 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.72 | 200 | 7,344 | 964,294 | 964.5 K to 964.3 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.71 | 100 | 3,671 | 964,494 | 964.6 K to 964.5 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.70 | 1,500 | 55,050 | 964,594 | 966.1 K to 964.6 K (-0.16 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.69 | 3,200 | 117,408 | 966,094 | 969.3 K to 966.1 K (-0.33 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.66 | 1,100 | 40,326 | 969,294 | 970.4 K to 969.3 K (-0.11 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.65 | 100 | 3,665 | 970,394 | 970.5 K to 970.4 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.62 | 100 | 3,662 | 970,494 | 970.6 K to 970.5 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.61 | 100 | 3,661 | 970,594 | 970.7 K to 970.6 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.60 | 700 | 25,620 | 970,694 | 971.4 K to 970.7 K (-0.07 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.59 | 100 | 3,659 | 971,394 | 971.5 K to 971.4 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.58 | 300 | 10,974 | 971,494 | 971.8 K to 971.5 K (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.57 | 200 | 7,314 | 971,794 | 972 K to 971.8 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.56 | 100 | 3,656 | 971,994 | 972.1 K to 972 K (-0.01 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.55 | 1,800 | 65,790 | 972,094 | 973.9 K to 972.1 K (-0.18 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.53 | 200 | 7,306 | 973,894 | 974.1 K to 973.9 K (-0.02 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 36.52 | 1,000 | 36,520 | 974,094 | 975.1 K to 974.1 K (-0.10 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.80 | 300 | 11,640 | 1,038,194 | 1 M to 1 M (-0.03 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.65 | 2,200 | 85,030 | 1,038,494 | 1 M to 1 M (-0.21 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.64 | 3,900 | 150,696 | 1,040,694 | 1 M to 1 M (-0.37 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.63 | 2,600 | 100,438 | 1,044,594 | 1 M to 1 M (-0.25 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.58 | 4,900 | 189,042 | 1,047,194 | 1.1 M to 1 M (-0.47 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.55 | 4,600 | 177,330 | 1,052,094 | 1.1 M to 1.1 M (-0.44 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.54 | 1,000 | 38,540 | 1,056,694 | 1.1 M to 1.1 M (-0.09 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.52 | 3,000 | 115,560 | 1,057,694 | 1.1 M to 1.1 M (-0.28 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.51 | 2,500 | 96,275 | 1,060,694 | 1.1 M to 1.1 M (-0.24 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.50 | 5,500 | 211,750 | 1,063,194 | 1.1 M to 1.1 M (-0.51 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.45 | 3,700 | 142,265 | 1,068,694 | 1.1 M to 1.1 M (-0.35 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.41 | 800 | 30,728 | 1,072,394 | 1.1 M to 1.1 M (-0.07 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.25 | 2,600 | 99,450 | 1,073,194 | 1.1 M to 1.1 M (-0.24 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.24 | 1,100 | 42,064 | 1,075,794 | 1.1 M to 1.1 M (-0.10 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.20 | 2,900 | 110,780 | 1,076,894 | 1.1 M to 1.1 M (-0.27 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.17 | 700 | 26,719 | 1,079,794 | 1.1 M to 1.1 M (-0.06 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.16 | 500 | 19,080 | 1,080,494 | 1.1 M to 1.1 M (-0.05 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.15 | 600 | 22,890 | 1,080,994 | 1.1 M to 1.1 M (-0.06 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.11 | 1,200 | 45,732 | 1,081,594 | 1.1 M to 1.1 M (-0.11 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.11 | 600 | 22,866 | 1,082,794 | 1.1 M to 1.1 M (-0.06 %) |
May 27 2004 | PHRM | PHARMION CORP | ATWOOD BRIAN G | Director | Sell | S | 38.10 | 100 | 3,810 | 1,083,394 | 1.1 M to 1.1 M (-0.01 %) |